眼附属器黏膜相关组织边缘区淋巴瘤诊疗进展  

Diagnosis and treatment progress of ocular adnexa mucosa-associated marginal zone lymphoma

作　　者：丛佳[1] 王景文[1] Cong Jia;Wang Jingwen(Department of Hematology,Beijing Tongren Hospital,Capital Medical Liniversity,Beijing 100730, China)

机构地区：[1]首都医科大学附属北京同仁医院血液内科,100730

出　　处：《白血病．淋巴瘤》2019年第2期121-124,共4页Journal of Leukemia & Lymphoma

摘　　要：原发眼附属器黏膜相关组织边缘区淋巴瘤是最常见的眼附属器淋巴瘤。近年来其发病率不断增高,一些免疫学、分子生物学的技术能更好地鉴别淋巴瘤与其他淋巴病变。影像学也能更好地评判分期,除了放疗、化疗,包括抗生素治疗与免疫治疗等多种治疗手段取得了一些明确的疗效。现就该病在诊断、分期、治疗的研究进展进行综述。Primary ocular adnexal mucosa-associated marginal zone lymphoma is the most common ocular adnexal lymphoma. In recent years, its incidence has been increasing, and some techniques of immunology and molecular biology can make us better identify lymphoma with other lymphadenopathies, and some imaging tools can better judge the stage. In addition to radiotherapy and chemotherapy, antibiotic therapy and immune therapy have made progresses in treatment. This paper reviews the research progress of the diagnosis, staging and treatment of the disease.

关 键 词：眼肿瘤 淋巴瘤 B细胞 边缘区 眼附属器 

分 类 号：R739.7[医药卫生—肿瘤]